Matthew Holian > DLA Piper LLP (US) > Boston, United States > Lawyer Profile

DLA Piper LLP (US)
33 ARCH STREET
26TH FLOOR
BOSTON MA 02110-1447
United States

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship; Life Sciences; Healthcare

Position

Partner; Global Co-Chair, Life Sciences Sector

Career

Matt Holian serves as the Global Co-Chair of DLA Piper’s Life Sciences Sector. Matt’s practice focuses on litigation, regulatory and enforcement challenges facing pharmaceutical and medical device companies. His litigation practice primarily involves serving as national counsel in complex, multi-jurisdictional product liability suits, for DLA Piper’s Product Liability and Mass Tort practice group.

In addition to his litigation practice, Matt also has an active regulatory and enforcement practice, which includes conducting compliance investigations, counseling clients regarding research and development issues (including defending hundreds of claims asserted by patients in clinical trials) and advising life sciences and other clients on a wide range of emerging regulatory issues, such as product labeling, First Amendment challenges to promotional restrictions, real word evidence and value-based contracts.

Memberships

Defense Research Institute

Education

J.D., Stanford University; B.A., Harvard University

Lawyer Rankings

United States > Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices

(Leading lawyers)

Matthew HolianDLA Piper LLP (US)

The ‘extremely responsive and thoughtful’ team at DLA Piper LLP (US) provides an ‘excellent client service and medical device knowledge’ to a wide range of pharmaceuticals companies, including Sanofi and Bayer, across a range of major product liability mandates. While the firm has a growing profile in trying cases, it is particularly adept at achieving an early conclusion of cases, through its effective use of dispositive pre-emption motions and Daubert challenges. Loren Brown in New York regularly acts as national co-ordinating counsel and lead trial counsel in mass torts and MDLs throughout the country, as well as in the context of global litigation – including her work for Bayer in mass tort litigation involving Essure. Based out of Atlanta, product liability chair Christopher Campbell is noted for his high-level strategic advice to manufacturers across a range of products, including many within the pharmaceutical space, where he is appreciated for his ‘guidance on the big picture’, as well his aptitude at handling cross-border mandates. Boston-based global co-chair of the firm’s life sciences sector, Matthew Holian is ‘super smart and very strategic‘ throughout the product life cycle, from risk assessment, pre-litigation discovery, bellwether trials and, ultimately, resolution. ‘Highly-skilled‘ Boston-based Katie Insogna excels at handling high-stakes litigation and counselling. Based out New York, Lucas Przymusinski provides ‘thoughtful guidance‘ to pharma companies across an array of regulatory and litigation matters, including product liability disputes, where his medical and science background provides additional benefit.

United States > Industry focus > Healthcare: life sciences

Clients praise DLA Piper LLP (US)‘s litigation offering, nothing that its ‘expert testimony is second to none.’ Product liability cases make up the majority of the team’s high profile work, including advising Sanofi, Bayer, and Novo Nordisk in state and federal court. It also advises pharmaceutical companies on consumer class actions. Commercially, the team acts on a transaction’s full life cycle, encompassing due diligence, company formation, and regulatory issues. Financing is another area of expertise, both via private placements and capital markets offerings. Matthew Holian and Andrew Gilbert co-chair the team from Boston and New Jersey respectively. New York-based Loren Brown heads the litigation practice, with extensive experience on mass torts cases. Baltimore-based Howard Schwartz acts on financings, and Boston-based Katie Insogna acts on product liability matters.